# Simultaneous Pancreas-kidney Transplantation With Campath Protocol

> **NCT00316810** · PHASE3 · COMPLETED · sponsor: **Dr. Claudia Bösmüller** · enrollment: 30 (actual)

## Conditions studied

- Pancreas-Kidney Transplantation

## Interventions

- **DRUG:** Alemtuzumab
- **DRUG:** Rabbit Anti-Human Thymocyte Globulin

## Key facts

- **NCT ID:** NCT00316810
- **Lead sponsor:** Dr. Claudia Bösmüller
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2006-04
- **Primary completion:** 2011-02
- **Final completion:** 2011-06
- **Target enrollment:** 30 (ACTUAL)
- **Last updated:** 2012-06-19

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00316810

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00316810, "Simultaneous Pancreas-kidney Transplantation With Campath Protocol". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT00316810. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*